These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22538522)

  • 61. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
    Amano K
    Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical trials. Gene transfer an unlikely contributor to patient's death.
    Kaiser J
    Science; 2007 Dec; 318(5856):1535. PubMed ID: 18063761
    [No Abstract]   [Full Text] [Related]  

  • 63. [Subacute cutaneous lupus erythematosus induced by golimumab].
    Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
    Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
    Inoue K; Takano H; Yanagisawa R; Yoshikawa T
    Chest; 2003 Jul; 124(1):413-4; author reply 414. PubMed ID: 12853558
    [No Abstract]   [Full Text] [Related]  

  • 65. Rheumatoid Arthritis - Anti-TNF.
    Chaabo K; Kirkham B
    Int Immunopharmacol; 2015 Aug; 27(2):180-4. PubMed ID: 25962818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monoclonal gammopathy of undetermined significance and anti-TNF-alpha treatment.
    Smale SW; Lawson TM
    Scand J Rheumatol; 2007; 36(5):405-6. PubMed ID: 17963174
    [No Abstract]   [Full Text] [Related]  

  • 67. Efficiency of potentiated antibodies to tumor necrosis factor-alpha (Artrofoon) in the therapy of patients with rheumatoid arthritis.
    Petrov VI; Babaeva AR; Cherevkova EV; Epstein OI; Sergeeva SA
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():155-8. PubMed ID: 12949686
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
    Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
    Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
    Furst DE; Keystone EC; Kirkham B; Kavanaugh A; Fleischmann R; Mease P; Breedveld FC; Smolen JS; Kalden JR; Burmester GR; Braun J; Emery P; Winthrop K; Bresnihan B; De Benedetti F; Dörner T; Gibofsky A; Schiff MH; Sieper J; Singer N; Van Riel PL; Weinblatt ME; Weisman MH
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii2-25. PubMed ID: 19022808
    [No Abstract]   [Full Text] [Related]  

  • 70. Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy.
    Ebker T; Rech J; von Wilmowsky C; Neukam FW; Stockmann P
    Rheumatology (Oxford); 2013 Jan; 52(1):218-20. PubMed ID: 23238981
    [No Abstract]   [Full Text] [Related]  

  • 71. [Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis].
    Pérez-Galán MJ; Salvatierra-Ossorio J; Cáliz-Cáliz R; Guzmán-Ubeda MA
    Med Clin (Barc); 2006 May; 126(19):757. PubMed ID: 16759594
    [No Abstract]   [Full Text] [Related]  

  • 72. Rheumatoid arthritis.
    Klareskog L; Catrina AI; Paget S
    Lancet; 2009 Feb; 373(9664):659-72. PubMed ID: 19157532
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".
    Seriolo B; Paoliono S; Ferrone C; Cutolo M
    Joint Bone Spine; 2009 Jan; 76(1):117-8; author reply 118. PubMed ID: 19084458
    [No Abstract]   [Full Text] [Related]  

  • 74. The effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
    Payet S; Pereira B; Soubrier M; Mathieu S
    Semin Arthritis Rheum; 2012 Feb; 41(4):e4-5; author reply e6. PubMed ID: 22154222
    [No Abstract]   [Full Text] [Related]  

  • 75. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Bijlsma JW; Burmester GR; Cronstein B; Keystone EC; Kavanaugh A; Klareskog L
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii2-7. PubMed ID: 12379612
    [No Abstract]   [Full Text] [Related]  

  • 76. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Emery P; Keystone EC; Schiff MH; van Riel PL; Weinblatt ME; Weisman MH
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii2-15. PubMed ID: 17038465
    [No Abstract]   [Full Text] [Related]  

  • 77. [Optimized treatment of a patient having rheumatoid arthritis and gout at the same time].
    Nordström D; Leirisalo-Repo M; Petterson T
    Duodecim; 2013; 129(10):1045-8. PubMed ID: 23767136
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Herpes zoster in the age of focused immunosuppressive therapy.
    Whitley RJ; Gnann JW
    JAMA; 2009 Feb; 301(7):774-5. PubMed ID: 19224757
    [No Abstract]   [Full Text] [Related]  

  • 79. Cigarette smoking, TB, and TNF inhibitors.
    Bieber J; Kavanaugh A
    Ann Rheum Dis; 2003 Nov; 62(11):1118-9. PubMed ID: 14583580
    [No Abstract]   [Full Text] [Related]  

  • 80. New and promising treatments for rheumatoid arthritis.
    Looney RJ; Stohl W
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):18-23. PubMed ID: 17694190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.